Login

Traffic Data on SKY TG24 Business | Pasqualino Monti - CEO of ENAV 00:10:00

Share On Facebook Share On Twitter

Pasqualino Monti is Chief Executive Officer of ENAV since 28 April 2023.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Building Bridges in Medical Dermatology|Steven M. Bosacki,Chief Executive Officer,Biopharmx Corp
00:10:00
HARNESSING THE POWER OF SCIENCE GLOBALLY|Carlo Rizzuto,Managing Director,Versant Ventures
00:10:00
Dennis Calvert’s Key Insights for Success in the Water Industry | Dennis Calvert , CEO, BioLargo Inc.
00:10:00
Offers promising founders investment with bespoke data insights and operating expertise|Andrés Dancausa,General Partner,TheVentureCity
00:10:00
Building Relationships With Other CXOs|Hagi Schwartz,Managing Director,Insight Partners
00:10:00
Thesis Gold and Benchmark Metals: A Transformative Merger for Precious Metals Development
00:10:00
Michael Bapis Discusses Client-Centric Wealth Management on TD Ameritrade Network
00:10:00
Tamago CEO Highlights Strategic Advancements and Undervalued Potential of Polymetallic Project in Northern Quebec
00:10:00
Insights on Real Estate Investment Trusts (REITs) and Property Market Trends: A Conversation with Carol Mills of Ayala Land's AREIT|CEO, AREIT, Inc
00:10:00
Momentus Stock Soars After Key National Security Agreement Termination
00:10:00
American Politics and Historical Perspectives: Jaffa on Lincoln's Era|Harry Jaffa
00:10:00
TCW understands the complex investment needs of institutions and individuals. Through constantly changing financial markets, TCW prides itself on providing products and solutions designed to meet the investment objectives of our clients | Katie Koch,Presi

© 2017 - Neuhu+